Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
JAMA Network Open
|
November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand
David I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Journal of Medical Radiation Sciences
|
January 12, 2021
Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy
Daryl Lim Joon, Michael Chao, Angelina Piccolo, et al.
BJU International
|
September 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians
Trent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2023
To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Wee Loon Ong, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2023
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2024
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival
Wee Loon Ong, James Stewart, Arjun Sahgal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR
Wee Loon Ong, John Nikitas, David Joseph, et al.
European Urology Oncology
|
February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials
Cristian Udovicich, Patrick Cheung, William Chu, et al.
BJUI Compass
|
July 22, 2025
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
Jennifer Ward, Kevin Armstrong, Therese Min-Jung Kang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
JAMA Network Open
|
November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand
David I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Journal of Medical Radiation Sciences
|
January 12, 2021
Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy
Daryl Lim Joon, Michael Chao, Angelina Piccolo, et al.
BJU International
|
September 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians
Trent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2023
To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Wee Loon Ong, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2023
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2024
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival
Wee Loon Ong, James Stewart, Arjun Sahgal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR
Wee Loon Ong, John Nikitas, David Joseph, et al.
European Urology Oncology
|
February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials
Cristian Udovicich, Patrick Cheung, William Chu, et al.
BJUI Compass
|
July 22, 2025
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
Jennifer Ward, Kevin Armstrong, Therese Min-Jung Kang, et al.
Page
of 7